Given that ROCK2 shows a strong correlation with RV dysfunction and has been shown to play a detrimental role in inflammation, oxidative stress, interstitial fibrosis, cardiac hypertrophy and impaired myocardial perfusion, ROCK2 inhibition may provide a viable target for early therapeutic intervention. Here, ROCK2 is linked to cardiac hypertrophy.